Strong Support
descriptive
Analysis v1
History

Taking a daily omega-3 supplement containing 460 mg EPA and 380 mg DHA for one year does not change the blood levels of five specific lipid molecules—Prostaglandin E2, Resolvin D2, Resolvin D5,...

69
Pro
0
Against

Mechanism

Synthesis from 1 study

How it works

Taking omega-3 supplements gives your body more building blocks to make certain anti-inflammatory chemicals, but it doesn’t make all of them. Your body picks which ones to produce based on how its enzymes work, and for some reason, the ones mentioned in the claim just don’t increase — even though...

Most probable mechanism

In Simple Terms

When people take omega-3 supplements, their bodies use the omega-3 fats to make certain anti-inflammatory chemicals, but not all of them. The body makes some of these chemicals like Resolvin D1 and D4, which help calm inflammation, but it doesn’t make more of the specific ones mentioned in the claim — like Resolvin D2, D5, E1, or others — even though the raw materials are there. This happens because the enzymes that build these chemicals only work on certain parts of the omega-3 fats, and the body’s system doesn’t push those particular pathways harder, even with more omega-3s.

Causal chain
1

Dietary EPA and DHA from supplementation are absorbed into the bloodstream and incorporated into phospholipid membranes of immune and endothelial cells

which leads to
2

Upon inflammatory activation, phospholipase enzymes release EPA and DHA from membrane phospholipids

which leads to
3

EPA and DHA are metabolized by lipoxygenase and cyclooxygenase enzymes into specialized pro-resolving mediators such as Resolvin D1 and Resolvin D4

which leads to
4

The enzymatic pathways responsible for producing Resolvin D2, Resolvin D5, Resolvin E1, and Leukotriene B4 are not upregulated despite increased substrate availability, resulting in no significant change in their circulating levels

which leads to
5

Concurrent reductions in other pro-inflammatory eicosanoids (PGD2, 5-HETE, 12-HETE) occur due to SPM-mediated feedback, while the targeted mediators in the claim remain unchanged due to pathway-specific enzyme kinetics or regulatory constraints

Evidence from Studies

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict